|
US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
PT1155689E
(pt)
|
1993-07-19 |
2007-01-31 |
Angiotech Pharm Inc |
Composições anti-angiogenicas e metodos de utilização
|
|
US5886026A
(en)
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
|
US5874029A
(en)
|
1996-10-09 |
1999-02-23 |
The University Of Kansas |
Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent
|
|
US5833891A
(en)
|
1996-10-09 |
1998-11-10 |
The University Of Kansas |
Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
|
|
ES2248847T3
(es)
|
1996-05-24 |
2006-03-16 |
Angiotech Pharmaceuticals, Inc. |
Composiciones y metodos para tratar o prevenir enfermedades de las vias de conduccion del cuerpo.
|
|
CA2189916C
(en)
|
1996-11-08 |
2001-01-16 |
Parkash S. Gill |
A new regime for paclitaxel in kaposi's sarcoma patients
|
|
US6515016B2
(en)
|
1996-12-02 |
2003-02-04 |
Angiotech Pharmaceuticals, Inc. |
Composition and methods of paclitaxel for treating psoriasis
|
|
US6495579B1
(en)
|
1996-12-02 |
2002-12-17 |
Angiotech Pharmaceuticals, Inc. |
Method for treating multiple sclerosis
|
|
US6982091B2
(en)
|
2001-08-29 |
2006-01-03 |
Umd, Inc. |
Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy
|
|
DK1023050T3
(da)
|
1997-06-27 |
2013-10-14 |
Abraxis Bioscience Llc |
Nye formuleringer af farmakologiske midler, fremgangsmåder til fremstillingen deraf og fremgangsmåder til anvendelsen deraf
|
|
US6004573A
(en)
|
1997-10-03 |
1999-12-21 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
US6117949A
(en)
|
1998-10-01 |
2000-09-12 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
IL131217A0
(en)
|
1998-03-10 |
2001-01-28 |
Napro Biotherapeutics Inc |
Novel methods and compositions for delivery of taxanes
|
|
US8293277B2
(en)
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
|
US6113795A
(en)
|
1998-11-17 |
2000-09-05 |
The University Of Kansas |
Process and apparatus for size selective separation of micro- and nano-particles
|
|
US6365191B1
(en)
|
1999-02-17 |
2002-04-02 |
Dabur Research Foundation |
Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
|
|
IN191203B
(enExample)
|
1999-02-17 |
2003-10-04 |
Amarnath Prof Maitra |
|
|
US6406722B1
(en)
|
1999-02-18 |
2002-06-18 |
Robert G. Gallaher |
Method of treating viral infections and lesions with taxane compounds
|
|
US7217735B1
(en)
|
1999-04-09 |
2007-05-15 |
Au Jessie L-S |
Methods and compositions for enhancing delivery of therapeutic agents to tissues
|
|
US6610317B2
(en)
|
1999-05-27 |
2003-08-26 |
Acusphere, Inc. |
Porous paclitaxel matrices and methods of manufacture thereof
|
|
DK1180020T4
(da)
|
1999-05-27 |
2009-10-05 |
Acusphere Inc |
Poröse lægemiddelmatrixer og fremgangsmåder til fremstilling deraf
|
|
US6892091B1
(en)
|
2000-02-18 |
2005-05-10 |
Biosense, Inc. |
Catheter, method and apparatus for generating an electrical map of a chamber of the heart
|
|
JP2004501143A
(ja)
|
2000-06-22 |
2004-01-15 |
ニトロメド インコーポレーテッド |
ニトロソ化およびニトロシル化タキサン、組成物および使用方法
|
|
US8178123B2
(en)
|
2001-08-29 |
2012-05-15 |
Femina Pharma Incorporated |
Method for augmentation of intraepithelial and systemic exposure of therapeutic agents having substrate activity for cytochrome P450 enzymes and membrane efflux systems following vaginal and oral cavity administration
|
|
CN1592607A
(zh)
|
2001-10-15 |
2005-03-09 |
克里蒂泰克公司 |
水溶性差药物的组合物、其给药方法和治疗方法
|
|
US20080220075A1
(en)
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
CA2479665C
(en)
|
2002-03-20 |
2011-08-30 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
KR100533458B1
(ko)
|
2002-07-20 |
2005-12-07 |
대화제약 주식회사 |
파클리탁셀의 가용화용 조성물 및 그의 제조 방법
|
|
AU2003304108B2
(en)
|
2002-10-30 |
2007-03-22 |
Spherics, Inc. |
Nanoparticulate bioactive agents
|
|
SI1585548T1
(sl)
|
2002-12-09 |
2018-11-30 |
Abraxis Bioscience, Llc |
Sestave in metode odmerjanja farmakoloških sredstev
|
|
ZA200507752B
(en)
|
2003-03-28 |
2007-01-31 |
Threshold Pharmaceuticals Inc |
Compositions and methods for treating cancer
|
|
FR2856301B1
(fr)
|
2003-06-23 |
2007-08-03 |
Galderma Res & Dev |
Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
|
|
US9149440B2
(en)
|
2003-09-02 |
2015-10-06 |
University Of South Florida |
Nanoparticles for drug-delivery
|
|
AU2004283464B8
(en)
|
2003-10-15 |
2011-04-14 |
Syncore Biotechnology Co., Ltd |
Method of administering cationic liposomes comprising an active drug
|
|
CA2544627A1
(en)
|
2003-11-05 |
2005-05-19 |
Elan Pharma International Ltd. |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
|
FR2862540B1
(fr)
|
2003-11-21 |
2007-03-30 |
Galderma Res & Dev |
Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
|
|
FR2871697B1
(fr)
|
2004-06-17 |
2007-06-29 |
Galderma Sa |
Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
|
|
FR2871695B1
(fr)
|
2004-06-17 |
2008-07-04 |
Galderma Sa |
Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
|
|
US7361683B2
(en)
|
2004-11-24 |
2008-04-22 |
Yung Shin Pharm. Ind., Co., Ltd |
Paclitaxel aqueous injection solution and methods for preparing the same
|
|
US8062658B2
(en)
|
2004-12-14 |
2011-11-22 |
Poly-Med, Inc. |
Multicomponent bioactive intravaginal ring
|
|
WO2006091780A2
(en)
|
2005-02-24 |
2006-08-31 |
Elan Pharma International Limited |
Nanoparticulate formulations of docetaxel and analogues thereof
|
|
GB0506139D0
(en)
|
2005-03-24 |
2005-05-04 |
Transphase Ltd |
A transdermal topical composition and its uses
|
|
JP5106384B2
(ja)
|
2005-04-27 |
2012-12-26 |
ライデン ユニバーシティ メディカル センター |
Hpv誘導性上皮内腫瘍の治療方法及び治療手段
|
|
WO2006133271A2
(en)
|
2005-06-06 |
2006-12-14 |
The General Hospital Corporation |
Compositions and methods relating to target-specific photodynamic therapy
|
|
CN101291658B
(zh)
|
2005-08-31 |
2014-04-16 |
阿布拉科斯生物科学有限公司 |
用于制备稳定性增加的水难溶性药物的组合物和方法
|
|
CA2633201A1
(en)
|
2005-12-14 |
2007-06-21 |
Organogenesis, Inc. |
Skin care compositions and treatments
|
|
US8906392B2
(en)
|
2005-12-16 |
2014-12-09 |
University Of Kansas |
Nanocluster compositions and methods
|
|
US8343962B2
(en)
|
2006-03-06 |
2013-01-01 |
Nuvo Research Inc. |
Topical formulation
|
|
EP2077823B1
(en)
|
2006-10-11 |
2012-06-27 |
Crititech, Inc. |
Method for precipitation of small medicament particles into use containers
|
|
CA2611803C
(en)
|
2006-11-22 |
2013-03-19 |
Bj Services Company |
Well treatment fluid containing viscoelastic surfactant and viscosification activator
|
|
SI2117520T1
(sl)
|
2006-12-14 |
2019-01-31 |
Abraxis Bioscience, Llc |
Zdravljenje raka dojk glede na status hormonskih receptorjev z nano delci, ki zajemajo taksan
|
|
TWI405590B
(zh)
|
2007-04-06 |
2013-08-21 |
Activus Pharma Co Ltd |
微粉碎化有機化合物粒子之製法
|
|
AU2008260447B2
(en)
|
2007-06-01 |
2013-10-10 |
Abraxis Bioscience, Llc |
Methods and compositions for treating recurrent cancer
|
|
ITMI20071267A1
(it)
|
2007-06-22 |
2008-12-23 |
Fidia Farmaceutici |
Uso di coniugati dell'acido ialuronico nel trattamento locale di malattie cutanee iperproliferative
|
|
HU227970B1
(en)
|
2007-07-10 |
2012-07-30 |
Egis Gyogyszergyar Nyrt |
Pharmaceutical compositions containing silicones of high volatility
|
|
CN101129338A
(zh)
|
2007-08-27 |
2008-02-27 |
四川大学 |
超临界流体新技术微细化抗癌药物紫杉醇
|
|
EP2222278B1
(en)
|
2007-11-28 |
2015-04-08 |
Celator Pharmaceuticals, Inc. |
Improved taxane delivery system
|
|
WO2009072007A2
(en)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
|
|
US8865194B1
(en)
|
2007-12-20 |
2014-10-21 |
Theraplex Company, LLC |
Reducing tackiness and greasiness of petrolatum-like materials
|
|
US20090175810A1
(en)
|
2008-01-03 |
2009-07-09 |
Gareth Winckle |
Compositions and methods for treating diseases of the nail
|
|
US8952075B2
(en)
|
2008-05-22 |
2015-02-10 |
Poly-Med, Inc. |
Bioactive polymeric liquid formulations of absorbable, segmented aliphatic polyurethane compositions
|
|
CN101283976A
(zh)
*
|
2008-05-30 |
2008-10-15 |
济南基福医药科技有限公司 |
一种含紫杉烷类药物的抗癌缓释凝胶注射剂
|
|
US9540695B2
(en)
|
2008-06-17 |
2017-01-10 |
Rosetta Genomics Ltd. |
Compositions and methods for prognosis of ovarian cancer
|
|
MX379265B
(es)
|
2008-06-26 |
2025-03-11 |
Anterios Inc |
Aplicacion dérmica de toxina botulínica en nanoemulsiones para usarse en el tratamiento de trastornos de la piel.
|
|
CA3062005C
(en)
|
2009-08-21 |
2022-02-15 |
Novan, Inc. |
Topical gels comprising nitric oxide-releasing polysiloxane macromolecules and uses thereof
|
|
GB2474930B
(en)
|
2009-10-02 |
2012-07-04 |
Foamix Ltd |
Topical tetracycline compositions
|
|
CN102686205A
(zh)
|
2009-10-02 |
2012-09-19 |
弗艾米克斯有限公司 |
局部四环素组合物
|
|
EP2488207A4
(en)
|
2009-10-13 |
2015-06-10 |
Rexahn Pharmaceuticals Inc |
POLYMERIC ANTIBODY RELEASE SYSTEMS
|
|
CN101829061A
(zh)
|
2010-05-14 |
2010-09-15 |
无锡纳生生物科技有限公司 |
一种紫杉醇纳米颗粒组合物及其制备方法
|
|
CN101843582B
(zh)
|
2010-05-18 |
2011-12-21 |
南京工业大学 |
紫杉醇纳米混悬剂及其制备方法
|
|
WO2011151418A2
(en)
|
2010-06-02 |
2011-12-08 |
Abbott Gmbh & Co. Kg |
Nanosusupension formulation comprising a polydimethylsiloxane hydrophobic phase
|
|
US8039494B1
(en)
|
2010-07-08 |
2011-10-18 |
Dow Pharmaceutical Sciences, Inc. |
Compositions and methods for treating diseases of the nail
|
|
EP2598114A1
(en)
|
2010-07-28 |
2013-06-05 |
Fondazione Irccs "Istituto Nazionale del Tumori" |
Therapeutic agent, composition including said agent, implantable device and process for the treatment of cervical cancer and/or for the prevention of the formation of neoplasms in correspondence of the cervix in a human female genital system.
|
|
US20130267490A1
(en)
|
2010-08-02 |
2013-10-10 |
Ranbaxy Laboratories Limited |
Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
|
|
US8563535B2
(en)
|
2011-03-29 |
2013-10-22 |
Kamal Mehta |
Combination composition comprising benzoyl peroxide and adapalene
|
|
WO2012130314A1
(en)
|
2011-03-31 |
2012-10-04 |
Elara Pharmaceuticals Gmbh |
Composition comprising docetaxel
|
|
WO2012135422A2
(en)
|
2011-04-01 |
2012-10-04 |
University Of Florida Research Foundation, Inc. |
Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
|
|
US20140073615A1
(en)
|
2011-05-02 |
2014-03-13 |
Lipidor Ab |
Treatment of Psoriasis
|
|
WO2013002636A1
(en)
|
2011-06-27 |
2013-01-03 |
Cristal Delivery B.V. |
Controlled release system
|
|
SI2833905T1
(en)
*
|
2012-04-04 |
2018-08-31 |
Halozyme, Inc. |
Combination therapy with hyaluronidase and tumane-directed taxane
|
|
US9018246B2
(en)
|
2012-09-05 |
2015-04-28 |
Lp Pharmaceutical (Xiamen) Co., Ltd. |
Transmucosal administration of taxanes
|
|
US9149455B2
(en)
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
|
JP2014114249A
(ja)
|
2012-12-11 |
2014-06-26 |
Kanae Technos:Kk |
基剤、及び皮膚外用剤
|
|
BR112015019524A8
(pt)
*
|
2013-03-04 |
2019-11-19 |
Astrazeneca Ab |
combinação de um composto [i] com um taxano, método de produção de efeito anticancer, uso de um composto [i] em combinação com um taxano, composição farmacêutica e kit no tratamento de câncer
|
|
US8778181B1
(en)
|
2013-03-14 |
2014-07-15 |
Crititech, Inc. |
Equipment assembly for and method of processing particles
|
|
EP2978420A4
(en)
|
2013-03-28 |
2016-12-21 |
Bbs Nanotechnology Ltd |
STABLE NANO COMPOSITION WITH DOXORUBICIN, PROCESS FOR THE PREPARATION THEREOF, THE USE THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREWITH
|
|
EA201690085A1
(ru)
|
2013-06-28 |
2016-06-30 |
Бинд Терапьютикс, Инк. |
Полимерные наночастицы доцетаксела для лечения рака
|
|
TWI601542B
(zh)
|
2014-04-18 |
2017-10-11 |
林信湧 |
一種用於治療肺癌之吸入式醫藥組成物及其備製方法
|
|
WO2015187194A1
(en)
|
2014-06-01 |
2015-12-10 |
Crititech, Inc. |
Use of paclitaxel particles
|
|
WO2016071365A1
(en)
|
2014-11-03 |
2016-05-12 |
Spherium Biomed, S.L. |
Topical pharmaceutical compositions of paclitaxel
|
|
CN105280869B
(zh)
|
2015-01-07 |
2018-07-31 |
保定钰鑫电气科技有限公司 |
一种组合式蓄电池端子连接片
|
|
WO2016197100A1
(en)
|
2015-06-04 |
2016-12-08 |
Crititech, Inc. |
Nozzle assembly and methods for use
|
|
AU2016323770A1
(en)
|
2015-09-16 |
2018-03-29 |
Dfb Soria, Llc |
Delivery of drug nanoparticles and methods of use thereof
|
|
PT3439635T
(pt)
|
2016-04-04 |
2021-02-11 |
Crititech Inc |
Formulações para tratamento de tumores sólidos
|
|
CN118948828A
(zh)
*
|
2017-03-15 |
2024-11-15 |
Dfb索里亚有限责任公司 |
使用紫杉烷纳米颗粒治疗皮肤恶性肿瘤的局部疗法
|